title: Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?
authors.forename: Tina T
authors.initials: TT
authors.lastname: Biss
authors.forename: Farhad
authors.initials: F
authors.lastname: Kamali
mesh_terms: D000293:Adolescent; D000925:Anticoagulants / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D054316:Biomarkers, Pharmacological; D001777:Blood Coagulation / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D065729:Cytochrome P-450 CYP2C9; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007223:Infant; D019934:International Normalized Ratio; D006899:Mixed Function Oxygenases / Q000235:genetics; D011110:Polymorphism, Genetic; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D054316:Biomarkers, Pharmacological; D014859:Warfarin; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases